The citations below is a result of Institute
for Scientific Information Science
Citation Index search
Citing Article
Biochemical
characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal
fluid: Association with high density lipoproteins
Koudinov AR, Koudinova NV, Kumar A, et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
223: (3) 592-597 JUN 25 1996
51
papers by July 20, 2001
(please note: selected papers provide
links to the PubMed abstracts)
41-51
Koudinov AR, Koudinova NV
Essential role for cholesterol in synaptic plasticity
and neuronal degeneration
FASEB J 15 (8): U181-U204 JUN 2001
Beisiegel U, Spector AA
Lipids and lipoproteins in the brain
CURR OPIN LIPIDOL 12 (3): 243-244 JUN 2001
Kontush A, Berndt C, Weber W,
et al.
Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal
fluid and plasma
FREE RADICAL BIO MED 30: (1) 119-128 JAN 1 2001
Munson GW, Roher AE, Kuo YM,
et al.
SDS-stable complex formation between native apolipoprotein E3 and beta-amyloid
peptides
BIOCHEMISTRY-US 39: (51) 16119-16124 DEC 26 2000
Danik M, Champagne D, Petit-Turcotte
C, et al.
Brain lipoprotein metabolism and its relation to
neurodegenerative disease
CRIT REV NEUROBIOL 13: (4) 357-407 1999
Fagan AM, Holtzman DM
Astrocyte lipoproteins, effects of apoE on neuronal
function, and role of apoE in amyloid-beta deposition in vivo
MICROSC RES TECHNIQ 50: (4) 297-304 AUG 15 2000
Calero M, Rostagno A, Matsubara
E, et al.
Apolipoprotein J (clusterin) and Alzheimer's disease
MICROSC RES TECHNIQ 50: (4) 305-315 AUG 15 2000
Cole GM, Ard MD
Influence of lipoproteins on microglial degradation
of Alzheimer's amyloid beta-protein
MICROSC RES TECHNIQ 50: (4) 316-324 AUG 15 2000
Fagan AM, Younkin LH, Morris
JC, et al.
Differences in the A beta 40/A beta 42 ratio associated
with cerebrospinal fluid lipoproteins as a function of
apolipoprotein E genotype
ANN NEUROL 48: (2) 201-210 AUG 2000
Jensen M, Hartmann T, Engvall
B, et al.
Quantification of Alzheimer amyloid beta peptides
ending at residues 40 and 42 by novel ELISA systems
MOL MED 6: (4) 291-302 APR 2000
Koudinova NV, Koudinov AR,
Yavin E
Alzheimer's A beta(1-40) peptide modulates lipid
synthesis in neuronal cultures and intact rat fetal brain under normoxic
and oxidative stress conditions
NEUROCHEM RES 25: (5) 653-660 MAY 2000
31-40
LaDu MJ, Reardon C, Van Eldik
L, et al.
Lipoproteins in the central nervous system
ANN NY ACAD SCI 903: 167-175 2000
Demeester N, Castro G, Desrumaux
C, et al.
Characterization and functional studies of lipoproteins,
lipid transfer proteins, and lecithin : cholesterol acyltransferase in
CSF of normal individuals and patients with Alzheimer's disease
J LIPID RES 41: (6) 963-974 JUN 2000
Fukuyama R, Mizuno T, Mori
S, et al.
Age-dependent decline in the apolipoprotein e level
in cerebrospinal fluid from control subjects and its increase in cerebrospinal
fluid from patients with Alzheimer's disease
EUR NEUROL 43: (3) 161-169 2000
Olesen OF, Dago L
High density lipoprotein inhibits assembly of amyloid
beta-peptides into fibrils
BIOCHEM BIOPH RES COM 270: (1) 62-66 APR 2 2000
Schippling S, Kontush A, Arlt
S, et al.
Increased lipoprotein oxidation in Alzheimer's disease
FREE RADICAL BIO MED 28: (3) 351-360 FEB 1 2000
Heininger K
A unifying hypothesis of Alzheimer's disease. III.
Risk factors
HUM PSYCHOPHARM CLIN 15: (1) 1-70 JAN 2000
Koudinov AR, Koudinova NV,
Berezov TT, et al.
HDL phospholipid: a natural inhibitor of Alzheimer's amyloid beta-fibrillogenesis?
CLIN CHEM LAB MED 37: (10) 993-994 OCT 1999
Tomiyama T, Corder EH, Mori H
Molecular pathogenesis of apolipoprotein E-mediated amyloidosis in late-onset
Alzheimer's disease
CELL MOL LIFE SCI 56: (3-4) 268-279 OCT 15 1999
Fagan AM, Holtzman DM, Munson
G, et al.
Unique
lipoproteins secreted by primary astrocytes from wild type, apoE (-/-),
and human apoE transgenic mice
J BIOL CHEM 274: (42) 30001-30007 OCT 15 1999
Scharnagl H, Tisljar U, Winkler
K, et al.
The
beta A4 amyloid peptide complexes to and enhances the uptake of beta-very
low density lipoproteins by the low density lipoprotein receptor-related
protein and heparan sulfate proteoglycans pathway
LAB INVEST 79: (10) 1271-1286 OCT 1999
21-30
-
Cole GM, Beech W, Frautschy SA,
et al.
-
Lipoprotein
effects on A beta accumulation and degradation by microglia in vitro
J NEUROSCI RES 57: (4) 504-520 AUG 15 1999
-
Roher AE, Kuo YM, Kokjohn KM,
et al.
-
Amyloid
and lipids in the pathology of Alzheimer disease
AMYLOID 6: (2) 136-145 JUN 1999
-
Koudinova NV, Berezov TT, Koudinov
AR
-
beta-amyloid:
Alzheimer's disease and brain beta-amyloidoses
BIOCHEMISTRY-MOSCOW+ 64: (7) 752-757 JUL 1999
-
Mulder M, Terwel D
-
Possible
link between lipid metabolism and cerebral amyloid angiopathy in Alzheimer's
disease: A role for high-density lipoproteins?
HAEMOSTASIS 28: (3-4) 174-194 MAY-AUG 1998
-
Kuo YM, Emmerling MR, Lampert
HC, et al.
-
High
levels of circulating A beta 42 are sequestered by plasma proteins in Alzheimer's
disease
BIOCHEM BIOPH RES CO 257: (3) 787-791 APR 21 1999
-
Kowalewski T, Holtzman DM
-
In
situ atomic force microscopy study of Alzheimer's beta-amyloid peptide
on different substrates: New insights into mechanism of beta-sheet formation
P NATL ACAD SCI USA 96: (7) 3688-3693 MAR 30 1999
-
Holtzman DM, Bales KR, Wu S,
et al.
-
Expression
of human apolipoprotein E reduces amyloid-beta deposition in a mouse model
of Alzheimer's disease
J CLIN INVEST 103: (6) R15-R21 MAR 1999
-
Shao HY, Jao SC, Ma K, et al.
-
Solution
structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides
of Alzheimer's disease
J MOL BIOL 285: (2) 755-773 JAN 15 1999
-
Bernoud N, Fenart L, Moliere
P, et al.
-
Preferential
transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro
blood-brain barrier over unesterified docosahexaenoic acid
J NEUROCHEM 72: (1) 338-345 JAN 1999
-
Marcinowski KJ, Shao H, Clancy
EL, et al.
-
Solution structure model of residues 1-28 of the amyloid beta peptide when
bound to micelles
J AM CHEM SOC 120: (43) 11082-11091 NOV 4 1998
11-20
-
Frautschy SA, Horn DL, Sigel
JJ, et al.
-
Protease
inhibitor coinfusion with amyloid beta-protein results in enhanced deposition
and toxicity in rat brain
J NEUROSCI 18: (20) 8311-8321 OCT 15 1998
-
Kaplan B
-
Application of polyacrylamide slab gel electrophoresis to the analysis
and small-scale purification of amyloid proteins
ANAL CHIM ACTA 372: (1-2) 161-172 OCT 19 1998
-
Bernoud N, Fenart L, Benistant
C, et al.
-
Astrocytes
are mainly responsible for the polyunsaturated fatty acid enrichment in
blood-brain barrier endothelial cells in vitro
J LIPID RES 39: (9) 1816-1824 SEP 1998
-
Holtzman DM, Fagan AM
-
Potential role of apoE in structural plasticity in the nervous system -
Implications for disorders of the central nervous system
TRENDS CARDIOVAS MED 8: (6) 250-255 AUG 1998
-
Koudinov AR, Berezov TT, Koudinova
NV
-
Alzheimer's
amyloid beta and lipid metabolism: a missing link?
FASEB J 12: (12) 1097-1099 SEP 1998
-
Beffert U, Danik M, Krzywkowski
P, et al.
-
The
neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's
disease
BRAIN RES REV 27: (2) 119-142 JUL 1998
-
Fagan AM, Murphy BA, Patel SN,
et al.
-
Evidence
for normal aging of the septo-hippocampal cholinergic system in apoE (-/-)
mice but impaired clearance of axonal degeneration products following injury
EXP NEUROL 151: (2) 314-325 JUN 1998
-
Kudinova NV, Beavis RC, Berezov
TT, et al.
-
Isolation
and characterization of soluble beta-amyloid and apolipoproteins from cerebrospinal
fluid
B EXP BIOL MED+ 124: (10) 995-998 OCT 1997
-
Koudinova NV, Berezov TT, Koudinov
AR
-
Alzheimer's
disease: Beta amyloid and lipid metabolism.
VOP MED KHIM 44: (1) 28-34 JAN-FEB 1998
-
LaDu MJ, Gilligan SM, Lukens
JR, et al.
-
Nascent
astrocyte particles differ from lipoproteins in CSF
J NEUROCHEM 70: (5) 2070-2081 MAY 1998
1-10
-
Sun YL, Wu S, Bu GJ, et al.
-
Glial
fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: Astrocyte-specific
expression and differing biological effects of astrocyte-secreted apoE3
and apoE4 lipoproteins
J NEUROSCI 18: (9) 3261-3272 MAY 1 1998
-
Koudinov AR, Berezov TT, Kumar
A, et al.
-
Alzheimer's
amyloid beta interaction with normal human plasma high density lipoprotein:
association with apolipoprotein and lipids
CLIN CHIM ACTA 270: (2) 75-84 FEB 23 1998
-
Rebeck GW, Alonzo NC, Berezovska
O, et al.
-
Structure
and functions of human cerebrospinal fluid lipoproteins from individuals
of different APOE genotypes
EXP NEUROL 149: (1) 175-182 JAN 1998
-
Urmoneit B, Prikulis I, Wihl
G, et al.
-
Cerebrovascular
smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein
pathway: Implications for cerebral amyloid angiopathy
LAB INVEST 77: (2) 157-166 AUG 1997
-
Koudinov AR, Koudinova NV
-
Alzheimer's
soluble amyloid beta protein is secreted by HepG2 cells as an apolipoprotein
CELL BIOL INT 21: (5) 265-271 MAY 1997
-
LaDu MJ, Lukens JR, Reardon CA,
et al.
-
Association
of human, rat, and rabbit apolipoprotein E with beta-amyloid
J NEUROSCI RES 49: (1) 9-18 JUL 1 1997
-
Farhangrazi ZS, Ying H, Bu GJ,
et al.
-
High
density lipoprotein decreases beta-amyloid toxicity in cortical cell culture
NEUROREPORT 8: (5) 1127-1130 MAR 24 1997
-
Puttfarcken PS, Manelli AM, Falduto
MT, et al.
-
Effect
of apolipoprotein E on neurite outgrowth and beta-amyloid-induced toxicity
in developing rat primary hippocampal cultures
J NEUROCHEM 68: (2) 760-769 FEB 1997
-
Carroll JA, Beavis RC
-
Using
matrix convolution filters to extract information from time-of-flight mass
spectra
RAPID COMMUN MASS SP 10: (13) 1683-1687 1996
-
Koudinova NV, Berezov TT, Koudinov
AR
-
Multiple
inhibitory effects of Alzheimer's peptide A beta 1-40 on lipid biosynthesis
in cultured human HepG2 cells
FEBS LETT 395: (2-3) 204-206 OCT 21 1996
Thanks for visiting Drs. Koudinov
Internet Office
Site Design and Programming © Alexei Koudinov, 2001.
Last updated: July 20, 2001